What is LOPJLB’s current signal on VTVT?

LOPJLB’s latest quantitative signal on vTv Therapeutics Inc. (VTVT) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is VTVT in?

vTv Therapeutics Inc. (VTVT) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does vTv Therapeutics Inc. (VTVT) do?

vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipeline features lead candidates such as TTP399, an oral, small-molecule, liver-specific glucokinase activator targeting Type 1 diabetes. Another key investigational drug is HPP737, an oral phosphodies…

Where is vTv Therapeutics Inc. based / listed?

vTv Therapeutics Inc. is based in US, listed on NASDAQ.

vTv Therapeutics Inc. (VTVT)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$30.08-3.00%Close

SELLRECOVERY · day 36

[SCORES & PROFILE]

FUND: 3
VALUE: 7
GROWTH: 39
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-3.8%

REV YoY-

ROE-6.3%

EPS YoY-

ROA-5.4%

GROSS

100

-25

NET

-13

[VALUATION]

P/E TTM-273.00

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B4.74

P/FCF-

EV/EBITDA1.26

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO12.48

ND/EBITDA-

BETA0.28

vTv Therapeutics Inc. (VTVT)

Key stats

Prediction markets

FUNDAMENTALS

Company news